Banzel (rufinamide) Briefing Materials for the March 23, 2018 Meeting of the Pediatric Advisory Committee
For the March 23, 2018 meeting of the FDA’s Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
Briefing Materials
- Banzel Pediatric Safety Review
- Banzel Pediatric Utilization Review
- Banzel Labeling, 6/2015
- Banzel Clinical Review
- Banzel Pharmacology Review